Know Labs, Inc. (NYSEAMERICAN:KNW) Short Interest Update

Know Labs, Inc. (NYSEAMERICAN:KNW) saw a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 341,800 shares, a growth of 11.3% from the May 15th total of 307,100 shares. Based on an average trading volume of 94,100 shares, the short-interest ratio is presently 3.6 days. Currently, 0.6% of the shares of the stock are short sold.

Institutional Investors Weigh In On Know Labs

A number of institutional investors have recently made changes to their positions in KNW. PFG Investments LLC bought a new position in shares of Know Labs during the first quarter worth about $113,000. Foguth Wealth Management LLC. acquired a new stake in Know Labs during the 1st quarter valued at approximately $60,000. Finally, Callan Capital LLC raised its holdings in Know Labs by 117.6% during the 4th quarter. Callan Capital LLC now owns 370,000 shares of the company’s stock worth $188,000 after purchasing an additional 200,000 shares during the last quarter. Institutional investors own 23.96% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Benchmark reiterated a “speculative buy” rating and issued a $1.00 target price on shares of Know Labs in a research report on Wednesday, May 29th.

Know Labs Price Performance

NYSEAMERICAN:KNW traded up $0.01 during mid-day trading on Friday, hitting $0.83. 390,034 shares of the company’s stock were exchanged, compared to its average volume of 148,510. Know Labs has a fifty-two week low of $0.23 and a fifty-two week high of $1.34. The company has a market cap of $71.20 million, a PE ratio of -2.45 and a beta of 1.48.

Know Labs (NYSEAMERICAN:KNW) last issued its quarterly earnings results on Wednesday, May 15th. The company reported ($0.07) EPS for the quarter.

Know Labs Company Profile

Know Labs, Inc, together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.